The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients' immune systems to target cancer, leading to several FDA-approved ...
This groundbreaking form of personalized cancer immunotherapy has had remarkable success — more than 45,000 cancer patients worldwide have been treated with CAR T-cell therapy, extending their lives ...
Please provide your email address to receive an email when new articles are posted on . When the first flow cytometry analysis was run after a CAR T-cell therapy, showing no evidence of leukemia, ...
CAMBRIDGE, Mass., Oct. 31, 2025 /PRNewswire/ -- The 2025 Richard N. Merkin Prize in Biomedical Technology was jointly awarded to Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results